Health Services Research
Latest posts by Health Services Research (see all)
- Evaluating Area-Based Socioeconomic Status Indicators for Monitoring Disparities within Health… - Sep. 15, 2014
- Facing the Recession: How Did Safety-Net Hospitals Fare Financially Compared with Their Peers? - Sep. 15, 2014
- The Impact of Massachusetts Health Care Reform on Access, Quality, and Costs of Care for the… - Sep. 15, 2014
- The Journey through Grief: Insights from a Qualitative Study of Electronic Health Record… - Sep. 15, 2014
Objective To compare the use of guideline-recommended prescription medications for diabetes among Medicare beneficiaries enrolled in stand-alone prescription drug plans (PDPs) with Medicare Advantage prescription drug plans (MAPDs) in the presence of potential selection bias. Data Sources/Study Setting Centers for Medicare and Medicaid Services’ Chronic Condition Data Warehouse (2006, 2007). Study Design Retrospective cross-sectional comparison of drug use and proportion of days covered (PDC) for oral-antidiabetics, ACE-inhibitors/ARBs, and antihyperlipidemics among PDP and MAPD enrollees with diabetes. We estimated nave regression models assuming exogenous plan choice and two-stage residual inclusion (2SRI) models to study endogeneity in choice of Part D plan type.
Originally posted here: